Production (Stage)
Bolt Biotherapeutics, Inc.
BOLT
$5.64
-$0.13-2.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.04M | -15.94M | -15.18M | -21.20M | -10.81M |
| Total Depreciation and Amortization | 399.00K | 426.00K | 440.00K | 457.00K | 458.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 827.00K | 2.28M | 1.35M | 2.82M | 2.04M |
| Change in Net Operating Assets | -3.55M | -1.20M | -578.00K | 1.77M | -8.44M |
| Cash from Operations | -13.37M | -14.43M | -13.97M | -16.14M | -16.75M |
| Capital Expenditure | -- | 0.00 | -41.00K | -- | -- |
| Sale of Property, Plant, and Equipment | 963.00K | 0.00 | 148.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.59M | 12.23M | 17.03M | 18.00M | 10.20M |
| Cash from Investing | 14.55M | 12.23M | 17.14M | 18.00M | 10.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 29.00K | 0.00 | 79.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 29.00K | 0.00 | 79.00K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.19M | -2.17M | 3.17M | 1.94M | -6.55M |